Illumina

Illumina is a leader in genomics and human health, specializing in DNA sequencing and array-based life sciences technologies. Founded in San Diego in 1998, the company has grown significantly, generating annual revenue of $4.3 billion and operating in 165 countries. Illumina's innovative products are essential for research discovery and personalized health. The company offers advanced DNA sequencing technologies, responsible for over 90% of the world's sequencing data, and array-based technologies that have transformed large-scale genomics. Illumina's applications span various fields, including oncology, genetic diseases, reproductive health, and agriculture. Notable achievements include the first sequencing of an African human genome and contributions to consumer DNA testing through partnerships with companies like 23andMe and Ancestry. With nearly 10,000 employees across 34 locations, Illumina is recognized for its innovation and workplace culture, earning accolades from TIME, Fast Company, and Forbes. The company continues to advance genomic research and applications, making significant contributions to health and science.